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One hundred years ago, the devastating 1918/19 Spanish influenza pandemic took the lives 7 
of 50-100 million people, or 3-5 % of the world population (1). Influenza A virus (IAV) 8 
pandemics occur when an animal IAV crosses the species barrier, usually by acquiring a new 9 
genetic trait by reassortment (2). According to the 2017 National Risk Register of Civil 10 
Emergencies of the United Kingdom, the predicted impact severity of a full-blown influenza 11 
pandemic is at the highest level; greater than that of coastal flooding (tsunami), major industrial 12 
accidents, and attacks on crowded places or transport. Has the advent of vaccines and 13 
antivirals truly increased our preparedness for the next influenza outbreak, while we still 14 
struggle to predict which seasonal strains will circulate in the next flu season? Needless to 15 
say, much is unknown about the cell biology of influenza infection and how the virus interacts 16 
with the multitude of host cellular processes that enable infection. Virus entry mechanics can 17 
be explored as a target for anti-influenza therapy. To complement virus-host interaction 18 
studies using cell biology, biochemistry, and structural biology, robust live imaging strategies 19 
that offer high temporal and spatial resolution are essential. However, the influenza RNA 20 
genome is intolerant to large genetic insertions, and efforts to rescue viruses using GFP fused 21 
to viral core proteins have had limited success (3). This has unfortunately delayed the growth 22 
of influenza entry live imaging studies in the field. In PNAS, Qin et al. (4) develop a 23 
nanotechnology that labels influenza viral ribonucleoproteins (vRNPs) with Quantum Dots 24 
(QDs) – an approach that will advance the mechanistic understanding of influenza virus entry 25 
using live fluorescence microscopy.  26 
 27 
Influenza virus is a member of the Orthomyxoviridae family. It is an enveloped, single-stranded 28 
negative strand RNA virus with 8 pin-like genomic segments called vRNPs protected by a 29 
single M1 matrix shell. Each vRNP consists of oligomeric NP, viral RNA and viral polymerase 30 
made of PA, PB1, and PB2 subunits (5). A single NP molecule binds 24-27 nucleotides in vivo 31 
(6, 7) and also has two sets of nuclear localisation signals (NLSs), ensuring robust nuclear 32 
import of uncoated vRNPs during entry (8, 9). vRNPs are 10 nm in width and 30-110 nm in 33 
length (10), and package themselves into a revolving cylinder-like orientation adopting a 34 
typical “7 + 1” arrangement with 7 vRNPs surrounding a central one (11, 12). All 8 vRNA 35 
segments contain unique packaging sequences residing mainly in the 3’ and 5’ termini of each 36 
vRNA (13), ensuring packaging of 8 distinct vRNPs into budding particles. It is the swapping 37 
of these vRNP segments that contribute to genetic reassortment between strains that co-infect 38 
the same cell (2). 39 
 40 
Influenza virus uncoating can be broken down into three steps: priming, M1 shell uncoating, 41 
and vRNP debundling (Fig. 1, highlighted in cyan). In the priming step, the decreasing pH 42 
during endocytic trafficking renders the viral core uncoating-competent (14, 15). Opening of 43 
the M2 ion channels in the viral envelope allows influx of protons and potassium ions into the 44 
viral core, altering the core so that M1 and the vRNPs can dissociate once the core is delivered 45 
to the cytosol by fusion (14, 16-19). Priming is critical for infection since if the M2 channel is 46 
blocked by amantadine, viral fusion still happens but the viral particle remains stuck in late 47 
endosomes (15). After HA activation and fusion, M1 shell disassembly and vRNP debundling 48 
take place on the cytosolic surface of late endosomes (20, 21). Following fusion, unanchored 49 
ubiquitin chains are exposed from the viral core and activate histone deacetylase 6 (HDAC6) 50 
and the aggresome processing machinery (20). HDAC6 links the M1 shell to actomyosin, 51 
dynein and the microtubule network, and shearing forces from molecular motors break apart 52 
the shell. Following M1 shell uncoating, transportin 1 (TNPO1), a member of the importin β 53 
family proteins (22, 23), removes residual M1 from vRNPs by binding a PY-NLS signal at the 54 
M1 N-terminus (21). This debundles vRNPs and facilitates their nuclear import by importin α/β 55 
via the classical NLS pathway (8).  56 
 57 
Previously, microinjection of dye-labeled vRNPs into the cytoplasm and fluorescence in situ 58 
hybridization (FISH) have been used to study the behaviour of incoming vRNPs (24, 25). FISH 59 
studies of incoming vRNPs suggested that the separate vRNAs travel together until they reach 60 
the nucleus (25). Super-resolution imaging of incoming particles showed that vRNPs debundle 61 
before reaching the nucleus (21). When purified influenza vRNPs free of M1 were 62 
microinjected into cells, their nuclear accumulation was observed after 1 h of injection (26). 63 
Cores that consisted of vRNPs and M1 could not be imported into the nucleus. Thus the 64 
removal of M1 causes the dissociation of vRNPs from each other, ensuring their passage 65 
through the nuclear pore (14, 26). Single-particle tracking of microinjected, fluorescently 66 
labelled vRNPs, showed that vRNPs undergo multiple rounds of binding and release before 67 
finally being translocated through the nuclear pore (24).  68 
 69 
In PNAS, Qin et al. (4) tackle the vRNP debundling puzzle by generating infectious influenza 70 
virions that package vRNPs non-covalently labelled with a QD via the PA subunit of the 71 
polymerase. Their approach enables long-term imaging of individual vRNP segments in living 72 
cells from viral attachment to nuclear import. Live imaging single incoming vRNPs over an 73 
extended period of time requires dye brightness, photostability and a high signal-to-noise ratio, 74 
in all of which QDs are superior compared to GFP. How are QDs incorporated into infectious 75 
influenza virions? The IAV PR8 strain was genetically manipulated to express a biotin acceptor 76 
peptide (BAP) fused to the polymerase PA subunit. The rescued rPR8-PA-AP virus was 77 
genetically stable over multiple passages, and was thus used to replicate in BirA-expressing 78 
MDCK cells in the presence of biotin. Shortly after, streptavidin-coated QDs (SA-QDs) were 79 
introduced into these cells by lipofection to allow non-covalent binding of the QDs to 80 
biotinylated PA. Influenza virions generated using this method packaged up to five QDs in a 81 
single particle. Many (60%) virus particles, however, contained only one QD. Those that 82 
contained two QDs of different colour were used to live image vRNP uncoating. Co-detection 83 
with Rab7-ECFP revealed that the two different segments that colocalised in endosomes 84 
separated into single entities as they left the Rab7 compartment. If combined with viral fusion 85 
detection, the dual QD virions will prove even more informative. It is likely that soon after fusion 86 
M1 shell breakage and vRNP debundling take place efficiently on the cytosolic surface of late 87 
endosomes by the action of host factors HDAC6 (20) and TNPO1 (21). After debundling, the 88 
vRNPs undergo a three-stage movement as they import into the nucleus. 89 
  90 
In summary, this study is important because it provides continuous documentation of the 91 
vRNP’s journey from late endosomal escape to nuclear entry (4). The approach, however, has 92 
limitations. The separated QD signals during uncoating can indicate two sub-bundles of 1+7, 93 
2+6, 3+5, 4+4, or several sub-bundles e.g. 2+3+3, and not necessarily 8 single segments. 94 
Further, QDs are 2-10 nm in diameter and their virion incorporation decreases viral replication 95 
significantly. The physical presence of QDs will influence the properties of vRNP-vRNP 96 
interactions that regulate debundling mechanics. Thus a multifaceted approach using 97 
alternative labelling techniques such as FlAsH (27), wild-type viruses, and cellular loss-of-98 
function experiments using siRNA and CRIPSR/Cas warrants deeper investigation before we 99 
conclude the precise mechanism of influenza vRNP debundling. However, this study expands 100 
the toolbox that allows researchers to visualise virus-host interactions during virus entry at 101 
single molecule resolution in combination with host factors of mechanistic interest.  102 
 103 
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Figure Legend 177 
 178 
Figure 1. Stepwise entry and uncoating of IAV. Influenza virus is an enveloped single-stranded 179 
negative strand RNA virus. It contains within its M1 matrix shell 8 genomic segments called vRNPs 180 
that are bundled together. When infecting a new cell, the IAV virion binds to sialic acids on cell 181 
surface receptors and triggers its own endocytosis into early endosomes via clathrin-mediated or 182 
macropinocytic uptake. Endosome maturation is key to successful virus entry and uncoating. The 183 
decreasing pH in endosomes opens the M2 ion channels on the viral membrane allowing influx of 184 
protons and potassium ions into the viral core, altering the core so that M1 and the vRNPs can 185 
dissociate once the core is delivered to the cytosol by HA-activated fusion. After fusion, cytosolic 186 
uncoating factors HDAC6 and TNPO1 promote further disassembly of the M1 shell and vRNPs, 187 
respectively. The real-time entry and uncoating of vRNPs can be tracked and dissected in detail, 188 
by imaging two individual vRNPs labelled with a QD (shown inside the particle as large green and 189 
red circles). Figure adapted from (28). 190 
